Publication | Open Access
Elevated levels of mitochondrion‐associated autophagy inhibitor LRPPRC are associated with poor prognosis in patients with prostate cancer
54
Citations
36
References
2014
Year
LRPPRC levels may be used as an independent biomarker for patients with PCa at a late stage with poor prognosis.
| Year | Citations | |
|---|---|---|
Page 1
Page 1